On June 17, Mineralys Therapeutics, Inc. (NASDAQ:MLYS) reported positive topline data from its Phase 2 Explore-CKD trial of lorundrostat.

The Tides of Terraria crossover is live in Palworld, and there's a new location you can reach to find Terraria-themed Pals.

The Eye of Cthulhu is a new boss fight that was added with the Tides of Terraria update, and in order to find it, you need to make your way to the Terraria Dungeon, which can be found southeast of ...

Terraria's Eye of Cthulhu is featured in the promotional art for the update, and this looks to be a Pal-type monster that players can fight and potentially catch.

Huge Palworld x Terraria update is out now, lets you tame the Eye of Cthulhu Patch notes for the big Palworld x Terraria update are out, so here’s what’s new. Palworld’s long-awaited Terraria ...

Apart from the Eye of Cthulhu, there are other mobs that you can capture inside the Sealed Realm of Terraria dungeon. These include slimes that help you bounce higher and bats that will collect ...

The Palworld Terraria update is finally here and it comes with new Pals, mechanics, and a dungeon to bring you back to the Steam megahit.

The Palworld: Tides of Terraria update introduced many foes, one of which is the final boss of Terraria, the Moon Lord.

Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 liver disease study.

Biotech 4DMT lays off 25% of workforce while accelerating phase 3 eye gene therapy timeline By James Waldron Jul 3, 2025 4:52am 4D Molecular Therapeutics Cell & Gene Therapy layoffs wet AMD ...

BAYRY begins human trials for OpCT-001, an experimental cell therapy for treating primary photoreceptor diseases.